Article
Broadly Reactive Anti-VHH Antibodies for Characterizing, Blocking, or Activating Nanobody-Based CAR-T Cells
2024-09-22
Abstract excerpt
Production of chimeric antigen receptor T cell (CAR-T) therapies is dependent on the use of antibody reagents to label, isolate, and/or expand T cell products. We sought to create antibody-based tools that directly target the variable domain of heavy-chain only antibodies (VHH or nanobody) used in some CAR molecules. Two murine antibodies were identified which bind to distinct epitopes in the conserved framework r...
Topics
Open a Topic to create a Post that cites this publication.
- Bacteriophages and microbial interactions
- Complement system in diseases
- Glycosylation and Glycoproteins Research
- Monoclonal and Polyclonal Antibodies Research
- Protein purification and stability
- T-cell and B-cell Immunology
- vaccines and immunoinformatics approaches
- Viral Infectious Diseases and Gene Expression in Insects
Identifiers and source
- Literature Corpus work
- 7842ae58-6ddb-51bb-a22c-2967e745e0eb
- DOI
- 10.1101/2024.09.18.613561
